Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03898791
Title A Study of LY3295668 Erbumine in Participants With Extensive-stage Small-Cell Lung Cancer
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Eli Lilly and Company
Indications

lung small cell carcinoma

Therapies

LY3295668

Age Groups: adult | senior
Covered Countries USA | FRA | ESP | BEL

Facility Status City State Zip Country Details
Highlands Oncology Group Fayetteville Arkansas 72703 United States Details
Rocky Mountain Cancer Center Denver Colorado 80218 United States Details
H Lee Moffitt Cancer Center Tampa Florida 33612 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Washington University Medical School Saint Louis Missouri 63110 United States Details
Dartmouth Hitchcock Medical Center Lebanon New Hampshire 03756-0001 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Levine Cancer Institute- Carolinas Medical Center Charlotte North Carolina 28204 United States Details
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15232 United States Details
Prisma Health Cancer Institute Greenville South Carolina 29605 United States Details
Texas Oncology Cancer Center Austin Texas 78705 United States Details
Texas Oncology Fort Worth Fort Worth Texas 76104 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
US Oncology The Woodlands Texas 77380 United States Details
Tyler Cancer Center Tyler Texas 75702 United States Details
Grand Hopital de Charleroi-Site Notre-Dame Charleroi 6000 Belgium Details
Universitair Ziekenhuis Gent Gent 9000 Belgium Details
Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg Leuven 3000 Belgium Details
AZ Delta Roeselare 8800 Belgium Details
Institut Bergonie Bordeaux 33076 France Details
Centre Georges Francois Leclerc Dijon Cedex 21000 France Details
Centre de Lutte Contre le Cancer Leon Berard Lyon Cedex 08 69373 France Details
APHM Hôpital de la Timone Marseille 13385 France Details
Institut Curie Paris CEDEX 05 75248 France Details
Institut de Cancérologie de l'Ouest Centre René Gauducheau Saint Herblain Cedex 44805 France Details
National Cancer Center Hospital Chuo-Ku Tokyo 104-0045 Japan Details
Severance Hospital Yonsei University Health System Seoul Korea 03722 Korea, Republic of Details
Samsung Medical Center Seoul Korea 06351 Korea, Republic of Details
Asan Medical Center Seoul 05505 Korea, Republic of Details
Hospital Clinico Universitario Virgen de la Victoria Malaga Andalucia 29010 Spain Details
Institut Catala d'Oncologia L'Hospitalet de Llobregat Barcelona 08907 Spain Details
Hospital Universitari Vall d'Hebron Barcelona 08035 Spain Details
Hospital Universitario Ramon y Cajal Madrid 28034 Spain Details
Hospital Universitario 12 de Octubre Madrid 28041 Spain Details
Hospital Universitario La Fe de Valencia Valencia 46026 Spain Details
Dr.Abdurrahman Yurtaslan Ankara Oncology Training & Res Hosp Ankara 06200 Turkey Details
Ege University Faculty of Medicine Izmir 35100 Turkey Details
Guys/St. Thomas Hospital London Surrey SE1 9RT United Kingdom Details
Royal Marsden Hospital Sutton Surrey SM2 5PT United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field